yo, ppcn pharmacy, let's ftp by starting to collaborate and ......influenza testing, diagnosis,...
TRANSCRIPT
Yo, PPCN Pharmacy, Let's FtP by Starting to Collaborate and Listen!
Tuesday, October 6, 2020 9:00 AM-12:00 PM
Presenter: Nicholas Leon, PharmD and Danielle Mayer, PharmD
Target audience: Pharmacists
Program Level: Intermediate
Program Objectives:
1. Measure and interpret blood pressure and point of care blood glucose. 2. Counsel patients on how to engage in home monitoring of blood pressure and blood glucose. 3. Conduct a targeted cardiac and endocrine review of systems to assess for acute target organ damage in patients with hypertension and for hyper/hypoglycemia in patients with diabetes. 4. Based on patient-specific findings, develop an appropriate assessment and plan for patients with hypertension and type 2 diabetes mellitus. 5. Document relevant findings in an e-care plan format. 6. Discuss how to incorporate patient care skills used to assess hypertension and type 2 diabetes into a community pharmacy setting.
Program Description: UAN: 0159-0000-19-077-L04-P Activity Type: Knowledge Based Contact Hours: 3 Survey Link: https://www.papharmacists.com/surveys/default.asp?id=1474713
Ready for Round Two? Prepare your Community Pharmacy Before the Next Emergency or Disaster Wednesday, October 7, 2020 12:00 PM – 1:00 PM
Presenter: Danielle Kieck, PharmD
Target audience: Pharmacists
Program Level: Introductory
Program Objectives:
1. List the benefits of developing an emergency preparedness plan in the community setting 2. Describe elements included in a community pharmacy emergency preparedness plan 3. Identify strategies for implementing and updating an emergency preparedness plan
Program Description: The recent COVID-19 pandemic has emphasized the importance of being prepared for the unexpected. Even community pharmacies should have procedures and accessible resources to utilize during an emergency. This continuing education presentation will provide information on developing and implementing a community pharmacy emergency preparedness plan. UAN: 0159-0000-20-017-L04-P Activity Type: Knowledge Based Contact Hours: 1 Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_CommunityPrepSurvey
New Directions in Influenza Management: The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use Wednesday, October 7, 2020 3:00 PM – 4:00 PM
*This CE is not accredited by PPA. This CE is accredited by ProCE, Inc. ProCE is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Presenter: Jason E. Bowling, MD Associate Professor Department of Medicine Division of Infectious
Diseases UT Health San Antonio
Target audience: All pharmacists
Program Label: Introductory
Program Objectives:
1. Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications,
in accordance with current guideline recommendations
2. Determine the need for influenza treatment based on patient signs, symptoms, and accurate
interpretation of appropriate diagnostic tests when necessary
3. Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in
accordance with the latest evidence
Program Description: Differentiating influenza from other viruses, and treating high-risk patients in a
timely manner to avoid overburdening the healthcare system, has never been more relevant. Join us for
a timely, expert-led CPE program that will marry the current data and guideline recommendations on
influenza testing, diagnosis, and antiviral treatment with engaging whiteboard animation case studies,
so you are prepared to apply the latest updates in influenza to clinical practice now.
UAN: 0221-9999-20-243-L01-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.surveymonkey.com/r/RNLRQM5
Biologics and FDA-Approved Biosimilars Thursday, October 8, 2020 12:00 PM – 1:00 PM
Presenter: Bojana Stevich-Heemer, MS, PharmD, MEd, BCOP
Target Audience: Pharmacists
Program Label: Intermediate
Program Objectives:
1. Define biologics and biosimilars 2. Describe Food and Drug Administration (FDA) approval process for biosimilars
3. Identify major resources for pharmacists to obtain information about currently FDA-approved biosimilars
Program Description: Biologics and biosimilars are important parts of therapeutics. In this session definitions of biologics and biosimilars will be presented, the Food and Drug Administration (FDA) approval process for biosimilars will be explained, and the major resources for obtaining information about currently FDA-approved biosimilars will be identified. UAN: 0159-0000-20-016-L01-P Activity Type: Knowledge Based Contact Hours: 1 Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_BiosimilarsSurvey
Diving in to Continuous Glucose Monitoring Monday, October 12, 2020 9:15 AM – 10:15 AM
Presenter: Adriene Zook, PharmD, RPh
Target audience: Health System Pharmacists
Program label: Intermediate
Program Objectives:
1. To explore and understand the continuous glucose monitoring (CGM) devices available on the market today. 2. To have a working knowledge of patient owned CGM devices, how they work, how they are worn, and how the CGM device is key for patient quality of life. 3. To have a basic knowledge of where and how to access the data CGM devices capture and use this data to aid in blood glucose management during an acute event.
Program Description: Living in the 21st Century, medical technology offers many options for ways to
care for our patients. Specifically technology around management and care for patients with diabetes
the opportunities are endless and likely at times could seem to be overwhelming. Through this program
we will explore the various technology pieces on the market available for patient use for managing their
blood levels and treating their disease. We will also explore how to utilize and access these tools, which
may be encountered during an acute admission, and how these tools can provide oceans of information
to aid the decision making process for the treatment and management of blood glucose levels.
UAN: 0159-0000-20-031-L04-P Activity Type: Knowledge Based Contact Hours: 1 Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_CGMSurvey
Getting your feet wet with ISMP’s Targeted Medication Safety Best Practices Monday, October 12, 2020 10:30 AM – 11:30 PM __________________________________________________________________________________ Presenter: Christopher Walsh, RPh, PharmD, FISMP
Target audience: Health System Pharmacists
Program Label: Introductory
Program Objectives:
1. Discuss the background for the Institute for Safe Medication Practice’s (ISMP) Targeted Medication
Safety Best Practices (TMSBP)
2. Review ISMP’s TMSBP
3. Discuss how to use ISMP’s TMSBP to identify opportunities to reduce the risk of serious medication
events in hospitals
Program Description: ISMP’s Targeted Medication Safety Best Practices (TMSBP’s) were developed to
raise awareness and help organizations address consensus-based best practices to prevent fatal
medication errors that continue to occur. This program will review the current list of TMSBP’s and an
example of how to utilize the list as a medication safety tool.
UAN: 0159-0000-20-032-L04-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_ISMPSurvey
Making a SPLASH with Patient Care
Tuesday, October 13, 2020 1:00 PM – 2:00 PM
Presenter: Brett Nguyen, Kevin Nguyen, Jenna Januszka, David Katz, Matty Zimmerman
Target Audience: Pharmacists
Program Label: Introductory
Program Objectives: At the completion of this activity, the participant will be able to:
1. Discuss the potential mechanism behind the benefits of SGLT-2 inhibitors in patients with heart failure
2. Analyze primary literature evaluating the use of SGLT-2 inhibitors in patients with heart failure with
and without type 2 diabetes
3. List newly FDA-approved women’s health drugs.
4. Identify clinical pearls for the appropriate use of these agents.
5. Identify areas of safety concern in specific patient populations when medicinal cannabis is used, with
a focus on the cannabinoids THC and CBD.
6. Recognize federal and Pennsylvania laws that protect the pharmacist and their license from cannabis-
related litigation.
7. Discuss the shortcomings of standard therapies used for the treatment and prevention of migraine
disorders and identify potential candidates for newly approved pharmacotherapies
8. Describe the mechanism of action, efficacy, and safety of six newly approved pharmacotherapies for
the prevention and treatment of migraine disorders, including erenumab, fremanezumab,
galcanezumab, rimegepant, ubrogepant and lasmiditan.
Program Description:
UAN: 0159-0000-20-038-L04-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/default.asp?id=2020StudentCEPlatform
Life Preservers: Community Pharmacies and Medication Safety Programs Tuesday, October 13, 2020 3:15 PM – 4:15 PM
_______________________________________________________________________________
Presenter: Bethany Abrahams, PharmD, RPh
Target audience: All pharmacists and all technicians
Program Label: Introductory
Program Objectives:
1. Identify the stages in the dispensing process where medication errors commonly occur.
2. Indicate the types of errors that commonly occur in each stage of the dispensing process.
3. Review resources and tools available for community pharmacies looking to reduce medication errors
4. Discuss how to initiate a medication safety quality improvement initiative in a community pharmacy
5. Describe what steps can be taken to develop a culture of safety in a community pharmacy
Program Description: This session will cover practical methods to reduce medication errors in the
community pharmacy through a systems-based approach. Emphasis will be placed on identifying
common medication errors (and their causes), using this information to create quality improvement
plans, and promoting a culture of safety in your pharmacy.
UAN: 0159-0000-20-022-L05-P, 0159-0000-20-022-L05-T
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_MedicationSafetySurvey
(Pharmacists)
https://www.papharmacists.com/surveys/?id=2020AnnualCE_MedicationSafetySurvey_Tech
(Technicians)
Stopping the Replication: Strategies to Combat Respiratory Viral Infections
Wednesday, October 14, 2020 12:00 PM – 1:00 PM
Presenter: Letitia Warunek, PharmD, BCPS
Target audience: All pharmacists
Program Label: Introductory
Program Objectives:
1. Explain the epidemiology and pathophysiology of respiratory viral infections.
2. Discuss pharmacologic and non-pharmacologic treatment options for patients with respiratory viral
infections.
3. Describe the infection control and mitigation strategies for respiratory viral infections.
Program Description: Viral infections are a leading cause of upper and lower respiratory tract infections.
As a result of the COVID-19 pandemic, there is increased interest regarding the transmission, incubation
period, and overall impact of respiratory viral infections on patients in the community. The purpose of
this continuing education presentation is to review viral pathogenesis, discuss the evidence behind
various mitigation strategies, highlight the available pharmacologic and non-pharmacologic treatments
options, and assess the availability of vaccines for viral infections such as COVID-19, influenza, and other
common respiratory viral infections.
UAN: 0159-0000-20-023-L01-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_ViralInfectionsSurvey
2020 Pennsylvania Pharmacy and COVID Implications
Wednesday, October 14, 2020 4:00 PM – 5:30 PM
Presenter: Patricia Epple, CAE, CEO of the Pennsylvania Pharmacists Association
Target audience: All pharmacists and technicians
Program Label: Introductory
Program Objectives: (Pharmacists)
1. List recent legislative successes that impact pharmacists and pharmacy practice.
2. Explain current and upcoming pharmacy legislative and regulatory issues in Pennsylvania in 2020.
3. Review recent COVID related changes
4. Identify ways that pharmacists can be involved and impact these issues as pharmacy advocates.
5. Discuss current initiatives and activities underway to advance the profession in Pennsylvania.
Technician Objectives:
1. Outline any recent regulation or legislative changes and their impact on pharmacy in Pennsylvania.
2. Identify current and upcoming pharmacy legislative and regulatory issues in Pennsylvania in 2020.
3. Review recent COVID related changes
4. List ways that pharmacy technicians can be involved and impact these issues as pharmacy advocates.
5. Discuss current registration/licensure status for pharmacy technicians in Pennsylvania.
Program Description
UAN: 0159-0000-20-042-L03-P; 0159-0000-20-042-L03-T
Activity Type: Knowledge Based
Contact Hours: 1.5
Survey Link:
https://www.papharmacists.com/surveys/?id=2020PharmacyUpdateSurvey_P (Pharmacists)
https://www.papharmacists.com/surveys/?id=2020PharmacyUpdateSurvey_T (Technicians)
Sync or Swim: Diving Deep into Medication Synchronization
Thursday, October 15, 2020 9:00 AM – 10:00 AM
________________________________________________________________________________
Presenter: Hayley Fedorek, PharmD.
Target Audience: All Pharmacists
Program Label: Introductory
Program Objectives:
1. Identify the clinical benefits of Medication Synchronization
2. Recognize how to utilize Medication Synchronization and the appointment-based model to identify
drug therapy problems
3. Understand how to document common encounters in an E-Care Plan through Strand
4. Relate the concepts learned today to the other domains of the Flip the Pharmacy program
Program Description: This presentation will summarize the benefits of having a successful medication
synchronization program and explain how to utilize the program to make important interventions during
patient encounters using the appointment based model. It will also touch upon some documentation
tips for e-care plans as well as how medication synchronization contributes to other key aspects of the
Flip the Pharmacy transformation process.
UAN: 0159-0000-20-036-L01-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/default.asp?id=1481105
The current is changing: engaging patients with diabetes in an appointment based model
Thursday, October 15, 2020 10:15 AM – 11:15 AM
________________________________________________________________________________
Presenter: Nicole C Pezzino, PharmD, BCACP, CDCES
Target Audience: All pharmacists and all technicians
Program Label: Intermediate
Program Objectives:
1. Summarize the most recent guidelines on diabetes and the appointment based model
2. Apply Flip the Pharmacy domains to determine methods of engaging patients with diabetes in the
appointment-based model
3. Develop a plan for a practice patient case
Program Description:
UAN: 0159-0000-20-039-L01-P, 0159-0000-20-039-L01-T
Activity Type: Application Based
Contact Hours: 1
Survey Link:
https://www.papharmacists.com/surveys/default.asp?id=CurrentDiabetesCEpharmacists (pharmacists)
https://www.papharmacists.com/surveys/default.asp?id=CurrentDiabetesCEtechnicians (technicians)
Dedicated Admission Medication History Resource: Creating a New Role for Pharmacy Technicians and
Beyond
Friday, October 16, 2020 2:00 PM – 3:00 PM
________________________________________________________________________________
Presenter: Christopher Walsh, RPh, PharmD, FISMP
Target Audience: All pharmacists and all technicians
Program Label: Introductory
Program Objectives:
1. ‡Review current barriers to obtaining accurate medication histories for patients being admitted to
acute care facilities ‡
2. Discuss structure of pilot program utilizing dedicated resource for obtaining medication histories in
the Emergency Department setting ‡
3. Assess impact of a dedicated medication history resource on quality of medication histories ‡
4. Review potential next steps for medication history program expansion
Program Description:
UAN: 0159-0000-19-063-L01-P; 0159-0000-19-063-L01-T
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link:
https://www.papharmacists.com/surveys/?id=CEAdmissionMedication_Survey (pharmacists)
https://www.papharmacists.com/surveys/?id=CEAdmissions_TechnicianSurvey (technicians)
Medication Safety Considerations with Opioid Therapy
Monday, October 19, 2020 9:15 AM – 10:15 AM
_____________________________________________________________________________
Presenter: Melissa V Shiner, PharmD, BCGP, BCPP, MHA
Target Audience: Health System Pharmacists
Program Label: Introductory
Program Objectives:
1. Review potential adverse outcomes with concurrent prescribing of benzodiazepines and
gabapentinoids
2. Evaluate the risks of rapid opioid tapers
3. Discuss the identified adverse risks associated with stopping treatment of long-term opioids
Program Description: This CE will review the potential adverse outcomes of concurrent prescribing of
opioids with benzodiazepines and gabapentinoids. Discussion about risks of rapid opioid tapers and risks
associated with stopping long term opioids.
UAN: 0159-0000-20-027-L08-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_OpioidSurvey
Surfing Through Oral Chemotherapy Symptom Management
Monday, October 19, 2020 10:30 AM – 11:30 AM
_________________________________________________________________________
Presenter: Tristan Maiers, PharmD, BCOP
Target Audience: Health System Pharmacists
Program Label: Intermediate
Program Objectives:
1. Identify, assess, and grade common side effects in patients receiving oral chemotherapy, including
nausea and vomiting, diarrhea, hand-foot syndrome, and fatigue.
2. Choose appropriate pharmacologic and non-pharmacologic supportive care to treat common side
effects of oral chemotherapy based on patient parameters.
3. Discuss various methods to prevent side effects from occurring prior to initiation of oral
chemotherapy
Program Description: This session is focused on various oral chemotherapy agents used for hematologic
and oncologic disease states with topics including identifying side effects, grading toxicities,
pharmacologic and non-pharmacologic supportive care recommendations, and patient interviewing tips.
Using primary literature, guidelines, and first-hand patient experiences, this session will provide a
learning experience to help attendees care for patients receiving oral chemotherapy in many settings.
UAN: 0159-0000-20-028-L01-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_ChemotherapySurvey
Collaborating through the Channels of Patient Care (PC2)
Monday, October 19, 2020 2:00 PM – 3:30 PM
______________________________________________________________________________
Presenters: Lindsey Meston, PharmD, Ashley Firm, PharmD, Tracey D. Conti, MD, & Michael Geishauser,
PharmD.
Target audience: All Pharmacists
Program Label: Introductory
Program Objectives:
1. Discuss ways for pharmacists to develop successful collaborating partnerships with physician
practices.
2. Explore creative approaches for the integration of or embedding pharmacists in to medical practices.
3. Establish a personal action plan for implementing appropriate strategies for their specific practice site
Program Description:
UAN: 0159-0000-20-034-L04-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/default.asp?id=1474509
Diving into Pandemic Vaccine Planning
Wednesday, October 21, 2020 2:30 PM – 3:30 PM
_________________________________________________________________________
Presenter: Kim C. Coley, PharmD, FCCP & Chiara Gessler, PharmD
Target Audience: All pharmacists
Program Label: Introductory
Program Objectives:
1. Describe the key steps to become a pandemic vaccine provider with the Pennsylvania Department of
Health.
2. Identify ways to prepare for pandemic vaccine provision at your community pharmacy.
3. Assess your community pharmacy for pandemic vaccine preparedness.
Program Description:
UAN: 0159-0000-20-037-L06-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/default.asp?id=1482091
Dip Your Toes In: Medical Cannabis, What’s the Evidence?
Thursday, October 22, 2020 12:00 PM – 1:00 PM
_____________________________________________________________________________________
Presenter: Jenna Carmichael, PharmD
Target Audience: All Pharmacists
Program Label: Introductory
Program Objectives:
1. Describe the PA Medical Cannabis Program.
2. Discuss the evidence for common Program diagnoses such as pain, anxiety and cancer
3. Explore these diagnoses through a patient case.
Program Description: This program will discuss the available evidence for use of cannabis in common
conditions covered by the PA Medical Marijuana Act - Pain, Anxiety and Cancer. There will also be a brief
description of the program and cases to illustrate understanding.
UAN: 0159-0000-20-026-L04-P
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link: https://www.papharmacists.com/surveys/?id=2020AnnualCE_CannabisSurvey
Substance Use Disorder: Identification and Referral Part 2
Friday, October 23, 2020 6:00 PM – 9:00 PM
Saturday, October 24, 2020 9:00 AM – 1:00 PM
___________________________________________________________________________
Presenters: Janet K. Astle, BS, Pharm, EdD & Holly Lassila, DrPH, MSEd, RPh, LPC
Target Audience: Pharmacists enrolled in the Substance Use Disorder program
Program Label: Advanced
Program Objectives: 1. Describe the current trends associated with the prevalence of substance use disorders.
2. Explain the neuroscience related to substance use disorders.
3. Discuss the choice argument vs. disease model of substance use disorders.
4. Compare and contrast substance use disorders with other chronic diseases.
5. Explore the role of stigma as a barrier to treatment.
6. Describe the mechanism of action for categories of commonly abused substances.
7. List the primary adverse effects for categories of commonly abused substances.
8. List the primary withdrawal symptoms for categories of commonly abused substances.
9. Utilize the PDMP and pre-screening questions to identify patients at risk for substance use disorders.
10. Apply appropriate screening instruments to further refine and define the level of risk for substance use
disorders.
11. Explore patient cases that illustrate the administration and interpretation of screening instruments for
substance use disorders.
12. Describe the various frameworks that can be employed in motivational interviewing approaches.
13. Employ tools such as the readiness ruler, decisional matrix, and reflection that can be utilized in motivational
interviewing.
14. Explore example cases that illustrate motivational interviewing and the warm hand-off process for patients
who may be suffering from a substance use disorder.
15. Participate as a health care provider in a mock screening and intervention for a patient at risk for a
substance use disorder.
16. Play the role of a patient in a mock screening and intervention for an individual at risk for a substance use
disorder.
17. Evaluate the effectiveness of a fellow peer in a mock screening and intervention for a patient at risk for a
substance use disorder utilizing a rubric.
18. Participate in a debriefing session for the mock screening and intervention exercise.
19. Identify educational resources and materials relative to substance use disorders that can be made available
for distribution at the practice setting.
20. Build a list of area resources and referrals relative to substance use disorders that can be made available for
distribution at the practice setting.
21. Identify a contact and referral list that can be accessed for a warm hand-off.
22. Design a protocol for the practice site that can be followed when encountering an individual at risk for a
substance use disorder.
23. Identify appropriate billing codes for substance use disorder treatment planning.
24. Discuss proper documentation and follow-up for substance use disorder treatment planning
Program Description:
UAN: 0159-0000-19-015-L01-P
Activity Type: Application Based
Contact Hours: 7
Survey Link: https://www.papharmacists.com/surveys/default.asp?id=SubstanceUseDisorderPart2
Let’s Talk Stigma: The Opioid Epidemic and Pharmacy Practice
Tuesday, October 27, 2020 1:30 PM -2:30 PM
_______________________________________________________________________________
Presenter: Katie Doong, PharmD, TTS; Elizabeth Bunk, PharmD, NCTTP, & Joni Carroll, PharmD, BCACP,
CTTS
Target audience: All pharmacists and pharmacy technicians
Program Label: Introductory
Program Objectives:
Pharmacist & Technician Objectives:
1. Define at least three different types of stigma.
2. Explain implicit bias as it relates to opioid use disorder.
3. Describe at least one way stigma associated with opioid use disorder may impact the wellbeing of an
individual.
4. Name at least one way stigma associated with opioid use disorder may impact the way someone
receives healthcare.
Program Description: This program will provide information for pharmacists, pharmacy technicians, and
student pharmacists on identifying and understanding stigma that surrounds opioid use disorder in
pharmacy practice and barriers to healthcare related resources patients with opioid use disorder may
face. The goal of this CE is to help pharmacy clinicians and support staffs recognize potential stigmatizing
behaviors and improve the provision of culturally sensitive care for individuals with opioid use disorder.
UAN: 0159-0000-20-029-L08-P, 0159-0000-20-029-L08-T
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link:
https://www.papharmacists.com/surveys/?id=2020AnnualCE_StigmaSurvey (pharmacists)
https://www.papharmacists.com/surveys/?id=2020AnnualCE_StigmaSurveyTech (technicians)
Changing the Tide: Evaluating Prescriber Perceptions of Pharmacists’ Medication Safety Interventions
Wednesday, October 28, 2020 3:00 PM – 4:00 PM
_________________________________________________________________________
Presenters: Nicole C Pezzino, PharmD, BCACP, CDCES & Alexis Nicholson, PharmD
Audience: All pharmacists and pharmacy technicians
Program Label: Intermediate
Program Objectives:
Pharmacists:
1. Describe common barriers that exist in current practice between community pharmacists and
prescribers affecting communication and collaboration.
2. Examine prescriber workflow and communication preferences as they are related to interacting with
community pharmacists regarding mutual patients.
3. Compare and Contrast community pharmacist medication safety interventions to prescribers
Pharmacy Technicians:
1. Describe common barriers that exist in current practice between community pharmacists and
prescribers affecting communication and collaboration.
2. Examine prescriber workflow and communication preferences as they are related to interacting with
community pharmacists regarding mutual patients.
3. Compare and Contrast current workflow practices that encourage medication safety and physician
collaboration
Program Description: Practice interests include providing direct patient care, participating in community
outreach, and fostering the development of other pharmacy colleagues. Clinical areas of interest include
internal medicine, primary care, and medication therapy management.
UAN: 0159-0000-20-021-L04-P, 0159-0000-20-021-L04-T
Activity Type: Knowledge Based
Contact Hours: 1
Survey Link:
https://www.papharmacists.com/surveys/?id=2020AnnualCE_ChangingTideSurvey (pharmacists)
https://www.papharmacists.com/surveys/?id=2020AnnualCE_ChangingTideSurveyTech (technicians)